Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
-2.27M
-
Total reported value, excl. options
-
$5.72B
-
Value change
-
-$81.1M
-
Put/Call ratio
-
1.51
-
Number of buys
-
94
-
Number of sells
-
-101
-
Price
-
$41.02
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2021
282 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q3 2021.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), VANGUARD GROUP INC (5.52M shares), WELLINGTON MANAGEMENT GROUP LLP (5.25M shares), MORGAN STANLEY (4.71M shares), Silver Lake Group, L.L.C. (3.53M shares), TIGER GLOBAL MANAGEMENT LLC (2.35M shares), Atreides Management, LP (2.31M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (2.02M shares), FMR LLC (1.93M shares), and Carmignac Gestion (1.78M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.